Collplant to present at dawson james small cap growth conference on october 21st

Rehovot, israel, oct. 14, 2021 /prnewswire/ - collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that the company's deputy ceo & chief financial officer eran rotem, will present a company overview at the dawson james 6th annual small cap growth conference at the wyndham grand hotel in jupiter, florida. mr.
CLGN Ratings Summary
CLGN Quant Ranking